Usmani, Sahabi .
HRN: 21-22-79 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2022
CEFUROXIME 750MG (VIAL)
10/01/2022
10/07/2022
IV
200mg
Q8
Age With Moderate Dehydration T/c Uti, Wbc 26
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes